Active substance · J07AP01
Salmonella typhi ty21a live attenuated
Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ07
- Pharmacological subgroupJ07A
- Chemical subgroupJ07AP
- Chemical substanceJ07AP01Typhoid, oral, live attenuated
Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 1 medicine
All medicines with Salmonella typhi ty21a live attenuated
Every register, a page at a time. Strengths and packs are on each medicine’s page.
1 result
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Vivotif | Canada | 10000000000 CFU | Capsule (Enteric-Coated) | Marketed | Bavarian Nordic As |



